Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial
- 1 September 2017
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 140 (3) , 864-867.e5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revisionAllergy, 2016
- Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background TherapyThe Journal of Allergy and Clinical Immunology: In Practice, 2015
- An improved Peltier effect‐based instrument for critical temperature threshold measurement in cold‐ and heat‐induced urticariaJournal of the European Academy of Dermatology and Venereology, 2014
- Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysisJournal of Dermatological Science, 2014
- Physical UrticariaCurrent Allergy and Asthma Reports, 2012
- Acquired cold urticaria: clinical picture and update on diagnosis and treatmentClinical and Experimental Dermatology, 2007
- Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJournal of Allergy and Clinical Immunology, 2006
- Pathomechanisms in Physical UrticariaJournal of Investigative Dermatology Symposium Proceedings, 2001
- Idiopathic Cold Urticaria: In Vitro Demonstration of Histamine Release upon Challenge of Skin BiopsiesNew England Journal of Medicine, 1981
- Dermographia mediated by immunoglobulin EThe American Journal of Medicine, 1973